What is Parexel called now?
What is Parexel called now?
Contract research organization (CRO) Parexel announced on Jan. 11, 2021 that the company completed a strategic separation of its Informatics and Medical Imaging business, which has been established as a new company named Calyx.
Is Parexel a pharma company?
For over 35 years, Parexel and its clients, the world’s leading biopharmaceutical companies, have shared a crucial mission: to prevent and cure disease by delivering important new medicines and therapies to the patients who need them.
Who is the owner of Parexel?
Global clinical research organization PAREXEL International has agreed to be taken over from Pamplona Capital Management for $8.5 billion. Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management.
How much is Parexel worth?
Biopharmaceutical company Parexel confirmed Tuesday morning it will be acquired by Pamplona Capital for $88.10 per share in cash, in a transaction valued at approximately $5 billion.
Is Parexel sold?
Parexel is being sold for $8.5 billion by Pamplona Capital to Swedish private equity firm EQT and the private equity business of Goldman Sachs Asset Management.
Where are Parexel offices located?
Where are Parexel International offices? Parexel International has offices in Billerica, Baltimore, Bethesda, Cambridge and in 59 other locations. How many offices does Parexel International have?
What is the business model of PAREXEL?
Parexel International is a biopharmaceutical services company. It is engaged in providing clinical research, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide.
Who are PAREXEL International competitors?
Competitors of Parexel International include Syneos Health, PPD and ICON. Where is Parexel International headquarters? Parexel International headquarters is located at 8 Federal St, Billerica. Where are Parexel International offices?
What does PAREXEL International do for a living?
It is engaged in providing clinical research, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. Parexel International’s revenue was reported to be $2.44 b in FY, 2017 which is a 0.6% increase from the previous period.